Trevena Announces FDA Has Set PDUFA Date of August 7, 2020 for Oliceridine
FDA considers NDA resubmission a complete Class 2 responseUpdated guidance on extended cash runway, funding operations into Q1 2021CHESTERBROOK, Pa., […]
FDA considers NDA resubmission a complete Class 2 responseUpdated guidance on extended cash runway, funding operations into Q1 2021CHESTERBROOK, Pa., […]
THE WOODLANDS, Texas, March 05, 2020 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its fourth quarter and […]
BURLINGTON, Mass., March 05, 2020 (GLOBE NEWSWIRE) — Nuance®Communications, Inc. (NASDAQ: NUAN) today announced Nuance Gatekeeper, its AI-based biometrics solution […]
EXTON, Pa., March 05, 2020 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (“Idera” or “the company”) (NASDAQ: IDRA) today announced completion […]
LATHAM, N.Y., March 05, 2020 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ:PLUG), a leading provider of hydrogen engines and fueling […]
RESEARCH TRIANGLE PARK, N.C., March 05, 2020 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (Nasdaq: FENC; TSX: FRX), a specialty pharmaceutical […]
RESEARCH TRIANGLE PARK, N.C., March 05, 2020 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the first patients […]
CAMBRIDGE, Mass., March 05, 2020 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the […]
NEW YORK, March 05, 2020 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies […]
MISSISSAUGA, Ontario, March 05, 2020 (GLOBE NEWSWIRE) — Canada Carbon Inc. (the “Company”) (TSX-V: CCB) is pleased to announce that […]